Healthcare holds up in Q3 as crop business drags on Bayer
27 October 2009
Eleanor Malone
Please Login to read the full article.
27 October 2009
Eleanor Malone
eleanor.malone@informa.com
Growth in
Bayer's healthcare sales in the third quarter failed to compensate for a very poor quarter for its crop science division – which was hit by falling crop commodity prices and adverse weather conditions – and a significant year-on-year decline in its materials science business,...
Please Login to read the full article.
RELATED CONTENT
NEWS
- Bayer posts fourth quarter loss alongside strong sales in 2010
- EMA guidance points up challenges to biosimilar interferon beta developers
- Scotland says no to Halaven for breast cancer and yes to Levitra for erectile dysfunction
- With ED drug NDA in US FDA hands, Vivus seeks to grab niche market
COMMENT
Other Informa Comment
FEATURES
Other Informa Features
EVENTS
28 February 2012
Pestana Chelsea Bridge Hotel London
04 March 2012
The Marriott World Center, Orlando, Florida
26 March 2012
Copenhagen, Denmark
JOB OF THE WEEK
Promote your vacancy here
